Stay updated on Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, blocking access to the ClinicalTrials.gov entry. This reflects an access restriction rather than a content update to the study record.SummaryDifference21%

- Check18 days agoChange DetectedThe Melanoma label along with related topics and the MedlinePlus Genetics link were removed from the page, reducing disease-focused context and external reference options presented to readers.SummaryDifference0.1%

- Check32 days agoChange DetectedThe study record was updated with new arm descriptions, dosing details, and eligibility language, and an IPD sharing plan was added; a 'Results Posted' notice was also included to reflect recent outcomes.SummaryDifference3%

- Check46 days agoChange DetectedMerck sponsor details and IPD sharing resources were added, along with related informational links. The update expands the page with governance and data-sharing context for the trial.SummaryDifference82%

- Check53 days agoChange DetectedThe results status is updated to 'Results Submitted,' replacing the previous 'No Results Posted,' and the page revision has been updated to v3.6.5 (replacing v3.6.4).SummaryDifference0.1%

- Check60 days agoChange DetectedAdded related topic tags for Melanoma and MedlinePlus Genetics to the page. These additions enhance discoverability and connect users to broader melanoma information and genetic resources without changing the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.